fashion -WSS

fashion

author：explore 2025-10-02 00:39:50 - browse：9766

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Medicare has officially expanded its coverage policy for brain scans that detect a brain plaque associated with Alzheimer’s disease, the agency announced on Friday.

Amyloid PET scans are important tools to help determine whether patients with mild cognitive impairment are good candidates for new Alzheimer’s drugs, including Eisai and Biogen’s drug Leqembi, which means there will likely be an increase in demand for the scans as uptake increases.

Previously, Medicare limited coverage for the drug to patients enrolled in clinical studies, and only covered one scan in a patient’s lifetime. The new coverage policy removes those restrictions and delegates decisions about how many scans to cover to regional Medicare administrators.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Intarcia’s device

WSS

Humana’s losses in Medicare Advantage tank its stock

Vertex non

Medicare drug price negotiation legal challenge met with skepticism

Why Medicare shouldn’t cover every FDA

Why you shouldn’t ask, “What country has the best health care?”

It's been 20 years since Dolly the sheep. Where's my clone?

hotspot

fashion

hotspot

New air purifier tech could be key to improving indoor air quality

STAT Virtual Event: Putting AI to the Test

New air purifier tech could be key to improving indoor air quality

Zyn nicotine pouches become unlikely player in latest culture war

How to save PrEP access — and even expand it

Reconstructing family trees of blood cells may help predict disease

What does generative AI mean for health care? We asked experts

STAT Virtual Event: Putting AI to the Test

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

CommonSpirit Health keeps growing, even as it loses money

Wikipedia

Bernie Sanders is gearing up to subpoena pharma CEOs

Why are Kaiser Permanente staff considering a strike?

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Emergency workers more likely to restrain Black patients: study

Zyn nicotine pouches become unlikely player in latest culture war

knowledge

Wikipedia

explore

hotspot